Mitochondrial dysfunction in neurodegenerative diseases.
暂无分享,去创建一个
[1] Robert H. Brown,et al. Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis , 1997, Annals of neurology.
[2] H. Horvitz,et al. Superoxide Dismutase Concentration and Activity in Familial Amyotrophic Lateral Sclerosis , 1995, Journal of neurochemistry.
[3] B. Rosen,et al. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10 , 1997, Annals of neurology.
[4] J S Beckman,et al. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. , 1993, Biochemical Society transactions.
[5] M. Beal,et al. Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease , 1994, Journal of neurochemistry.
[6] K. Beyreuther,et al. Amyloidogenicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. , 1992, The Journal of biological chemistry.
[7] G. Perry,et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. , 1994, The American journal of pathology.
[8] F. Joó,et al. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophc lateral sclerosis , 1996, Annals of neurology.
[9] S. Thibodeau,et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.
[10] E. Stadtman,et al. A Familial Amyotrophic Lateral Sclerosis-associated A4V Cu,Zn-Superoxide Dismutase Mutant Has a Lower Km for Hydrogen Peroxide , 1997, The Journal of Biological Chemistry.
[11] K. Oka,et al. Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Beal. Huntington's disease, energy, and excitotoxicity , 1994, Neurobiology of Aging.
[13] H. Roder,et al. Phosphatase Resistance of ERK2 Brain Kinase PK40erk2 , 1995, Journal of neurochemistry.
[14] L. Toral-Barza,et al. Calcium stores in cultured fibroblasts and their changes with Alzheimer's disease. , 1996, Biochimica et biophysica acta.
[15] M. King,et al. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. , 1989, Science.
[16] M. MacDonald,et al. Frataxin gene of Friedreich's ataxia is targeted to mitochondria , 1997, Annals of neurology.
[17] M. Gurney,et al. Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation , 1997, Annals of neurology.
[18] E. Stopa,et al. Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain , 1995, Annals of neurology.
[19] Guy A. Rouleau,et al. SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries , 1996 .
[20] W. Hung,et al. Intense Superoxide Dismutase‐1 Immunoreactivity in Intracytoplasmic Hyaline Inclusions of Familial Amyotrophic Lateral Sclerosis with Posterior Column Involvement , 1996, Journal of neuropathology and experimental neurology.
[21] M. Kiyosawa,et al. Friedreich‐like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the α‐Tocopherol transfer protein gene , 1997, Annals of neurology.
[22] D. Borchelt,et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. W. Scott,et al. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] Patrizia Mecocci,et al. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.
[25] D. Muller,et al. Energy Metabolism and Quantal Acetylcholine Release: Effects of Botulinum Toxin, l‐Fluoro‐2,4‐Dinitrobenzene, and Diamide in the Torpedo Electric Organ , 1988, Journal of neurochemistry.
[26] B. Rosen,et al. Evidence for irnnairment of energy metabofism in vivo in Huntington's disease using localized 1H NMR spectroscopy , 1993, Neurology.
[27] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[28] M. Beal,et al. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice , 1998, Brain Research.
[29] J. Morrison,et al. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[30] T. Yoshimine,et al. Elevation of Plasma Nitric Oxide End Products during Focal Cerebral Ischemia and Reperfusion in the Rat , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[31] H. Thaler,et al. Inositol phosphates and intracellular calcium after bradykinin stimulation in fibroblasts from young, normal aged and Alzheimer donors , 1991, Neurobiology of Aging.
[32] M. Beal,et al. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] G. Binetti,et al. Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells , 1997, Neuroscience Letters.
[34] Michel Koenig,et al. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin , 1997, Nature Genetics.
[35] S. Sasaki,et al. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis , 1996, Neurology.
[36] S. Barnes,et al. Superoxide Dismutase Catalyzes Nitration of Tyrosines by Peroxynitrite in the Rod and Head Domains of Neurofilament‐L , 1997, Journal of neurochemistry.
[37] Charles D. Smith,et al. Frontal lobe phosphorus metabolism and neuropsychological function in aging and in alzheimer's disease , 1995, Annals of neurology.
[38] M. Beal,et al. Oxidative damage in Alzheimer's , 1996, Nature.
[39] D. Price,et al. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[40] H. Reichmann,et al. Electron transport chain defects in Alzheimer's disease. , 1994, Neurology.
[41] S. W. Davies,et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.
[42] J. Thompson,et al. Decreased Zinc Affinity of Amyotrophic Lateral Sclerosis‐Associated Superoxide Dismutase Mutants Leads to Enhanced Catalysis of Tyrosine Nitration by Peroxynitrite , 1997, Journal of neurochemistry.
[43] M. Beal,et al. Chronic 3-Nitropropionic Acid Treatment in Baboons Replicates the Cognitive and Motor Deficits of Huntington’s Disease , 1996, The Journal of Neuroscience.
[44] E. Le Rumeur,et al. Phosphocreatine synthesis by isolated rat skeletal muscle mitochondria is not dependent upon external ADP: a 31P NMR study. , 1996, Biochemical and biophysical research communications.
[45] Robert B. Wilson,et al. Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue , 1997, Nature Genetics.
[46] S. Hoyer. Intermediary metabolism disturbance in AD/SDAT and its relation to molecular events , 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[47] P. Matsudaira,et al. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. , 1994, The Journal of biological chemistry.
[48] J A Helpern,et al. In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia , 1989, Neurology.
[49] M. Albert,et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.
[50] A. Hirano. Cytopathology of amyotrophic lateral sclerosis. , 1991, Advances in neurology.
[51] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[52] D. Neary,et al. Mitochondrial function in brain tissue in primary degenerative dementia , 1987, Brain Research.
[53] D. Butterfield,et al. Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.
[54] N. Cairns,et al. An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease , 1997, Journal of neurochemistry.
[55] A. Laptook,et al. Journal of Cerebral Blood Flow and Metabolism Age-related Changes in Swine Brain Creatine Kinase-catalyzed 31p Exchange Measured in Vivo Using 31p Nmr Magnetization Transfer , 2022 .
[56] J. Nobrega,et al. Brain Cytochrome Oxidase in Alzheimer's Disease , 1992, Journal of neurochemistry.
[57] S. Kish,et al. Immunoreactive Levels of α-ketoglutarate Dehydrogenase Subunits in Friedreich's Ataxia and Spinocerebellar Ataxia Type 1 , 1996 .
[58] R. Brooks,et al. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis , 1987, Annals of neurology.
[59] G. Finocchiaro,et al. Glucose metabolism alterations in Friedreich's ataxia , 1988, Neurology.
[60] Joseph S. Beckman,et al. Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[61] F. Poccia,et al. Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH‐SY5Y cells , 1997, FEBS letters.
[62] A. Ludolph,et al. 3-Nitropropionic Acid - Exogenous Animal Neurotoxin and Possible Human Striatal Toxin , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[63] J. Pettegrew,et al. Phosphocreatine-dependent Glutamate Uptake by Synaptic Vesicles , 1996, The Journal of Biological Chemistry.
[64] Hidenao Fukuyama,et al. Altered energy metabolism in Alzheimer's disease , 1996, Journal of the Neurological Sciences.
[65] A. Ludolph,et al. Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[66] Y Yonekura,et al. Altered cerebral energy metabolism in Alzheimer's disease: a PET study. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[67] B. Yankner,et al. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro , 1995, Nature.
[68] P. Patel,et al. Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.
[69] V. Ingram,et al. Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[70] J. Parks,et al. Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.
[71] K. Beyreuther,et al. Amyloidogenicity of rodent and human βA4 sequences , 1993 .
[72] M. Koenig,et al. Ataxia with isolated vitamin E deficiency is caused by mutations in the α–tocopherol transfer protein , 1995, Nature Genetics.
[73] M. Beal,et al. S-Methylthiocitrulline, a Neuronal Nitric Oxide Synthase Inhibitor, Protects against Malonate and MPTP Neurotoxicity , 1997, Experimental Neurology.
[74] P. Ince,et al. Oxidative damage to protein in sporadic motor neuron disease spinal cord , 1995, Annals of neurology.
[75] Robert H. Brown,et al. Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral Sclerosis , 1993, Journal of neurochemistry.
[76] C. Eisdorfer,et al. A comparison of familial and sporadic Alzheimer's disease , 1993, Neurology.
[77] D. Perl,et al. Evidence of neuronal oxidative damage in Alzheimer's disease. , 1996, The American journal of pathology.
[78] Richard S. J. Frackowiak,et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease , 1995, Neuroscience Letters.
[79] W. Hemmer,et al. Functional aspects of creatine kinase in brain. , 1993, Developmental neuroscience.
[80] S. Maruyama,et al. Ultrastructure of swollen proximal axons of anterior horn neurons in motor neuron disease , 1990, Journal of the Neurological Sciences.
[81] M. Pandolfo,et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.
[82] J. Pettegrew,et al. Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia , 1995, Neurobiology of Aging.
[83] D. Borchelt,et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.
[84] J. Cooper,et al. Mitochondrial defect in Huntington's disease caudate nucleus , 1996, Annals of neurology.
[85] C. Kawas,et al. In Situ Labeling of Dying Cortical Neurons in Normal Aging and in Alzheimer’s Disease: Correlations with Senile Plaques and Disease Progression , 1996, Journal of neuropathology and experimental neurology.
[86] A. Roses,et al. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH , 1996, Nature Medicine.
[87] T. Matsuishi,et al. Elevated cerebrospinal fluid lactate/pyruvate ratio in Machado‐Joseph disease , 1996, Acta neurologica Scandinavica.
[88] A. Munnich,et al. Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia , 1997, Nature Genetics.
[89] Thomas Bourgeron,et al. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency , 1995, Nature Genetics.
[90] P. Swanson,et al. Biochemical abnormalities in Huntington's chorea brains , 1974, Neurology.
[91] R. Davis,et al. Cybrids in Alzheimer's disease: A cellular model of the disease? , 1997, Neurology.
[92] J. Piatigorsky,et al. Oxidative Stress Increases Production of -Amyloid Precursor Protein and -Amyloid (A) in Mammalian Lenses, and A Has Toxic Effects on Lens Epithelial Cells (*) , 1996, The Journal of Biological Chemistry.
[93] A. Joyner,et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. , 1995, Science.
[94] Mark Turmaine,et al. Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.
[95] W. D. de Grip,et al. No evidence for reduced thrombocyte cytochrome oxidase activity in Alzheimer's disease , 1992, Neurology.
[96] G. Reynolds,et al. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and γ-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases , 1985, Journal of the Neurological Sciences.
[97] L. Ellerby,et al. Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[98] Mark A. Smith,et al. 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.
[99] Bruce R. Rosen,et al. Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease , 1998, The Journal of Neuroscience.
[100] M. Goldberg,et al. Abnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[101] M. Dalakas,et al. Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study. , 1988, Journal of computer assisted tomography.
[102] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[103] H. Ito,et al. α-Tocopherol transfer protein gene: Exon skipping of all transcripts causes ataxia , 1997, Neurology.
[104] M. Beal,et al. Aging, energy, and oxidative stress in neurodegenerative diseases , 1995, Annals of neurology.
[105] V. Bambini,et al. Amyotrophic lateral sclerosis , 1996, Neurology.
[106] S. W. Davies,et al. Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.
[107] E. Mandelkow,et al. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[108] P. Kaldis,et al. 'Hot spots' of creatine kinase localization in brain: cerebellum, hippocampus and choroid plexus. , 1996, Developmental neuroscience.
[109] J. Schulz,et al. Striatal Malonate Lesions Are Attenuated in Neuronal Nitric Oxide Synthase Knockout Mice , 1996, Journal of neurochemistry.
[110] F. Nicoletti,et al. Ubiquinone Protects Cultured Neurons against Spontaneous and Excitotoxin-Induced Degeneration , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[111] D. Bredesen,et al. Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.
[112] E. Stadtman,et al. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[113] S. Gilman,et al. Structural and functional brain imaging in Friedreich's ataxia. , 1994, Archives of neurology.
[114] John X. Morris,et al. Increased risk of dementia in mothers of Alzheimer's disease cases , 1996, Neurology.
[115] Jason P. Sheehan,et al. Calcium Homeostasis and Reactive Oxygen Species Production in Cells Transformed by Mitochondria from Individuals with Sporadic Alzheimer’s Disease , 1997, The Journal of Neuroscience.
[116] M. Rudin,et al. Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain function. , 1993, The Journal of biological chemistry.
[117] M. Beal,et al. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia , 1997, Annals of neurology.